NK Cells and γδ T Cells Mediate Resistance to Polyomavirus–Induced Tumors
NK and γδ T cells can eliminate tumor cells in many experimental models, but their effect on the development of tumors caused by virus infections in vivo is not known. Polyomavirus (PyV) induces tumors in neonatally infected mice of susceptible strains and in adult mice with certain immune deficiencies, and CD8+ αβ T cells are regarded as the main effectors in anti-tumor immunity. Here we report that adult TCRβ knockout (KO) mice that lack αβ but have γδ T cells remain tumor-free after PyV infection, whereas TCRβ×δ KO mice that lack all T cells develop tumors. In addition, E26 mice, which lack NK and T cells, develop the tumors earlier than TCRβ×δ KO mice. These observations implicate γδ T and NK cells in the resistance to PyV-induced tumors. Cell lines established from PyV-induced tumors activate NK and γδ T cells both in culture and in vivo and express Rae-1, an NKG2D ligand. Moreover, these PyV tumor cells are killed by NK cells in vitro, and this cytotoxicity is prevented by treatment with NKG2D-blocking antibodies. Our findings demonstrate a protective role for NK and γδ T cells against naturally occurring virus-induced tumors and suggest the involvement of NKG2D-mediated mechanisms.
Vyšlo v časopise:
NK Cells and γδ T Cells Mediate Resistance to Polyomavirus–Induced Tumors. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000924
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000924
Souhrn
NK and γδ T cells can eliminate tumor cells in many experimental models, but their effect on the development of tumors caused by virus infections in vivo is not known. Polyomavirus (PyV) induces tumors in neonatally infected mice of susceptible strains and in adult mice with certain immune deficiencies, and CD8+ αβ T cells are regarded as the main effectors in anti-tumor immunity. Here we report that adult TCRβ knockout (KO) mice that lack αβ but have γδ T cells remain tumor-free after PyV infection, whereas TCRβ×δ KO mice that lack all T cells develop tumors. In addition, E26 mice, which lack NK and T cells, develop the tumors earlier than TCRβ×δ KO mice. These observations implicate γδ T and NK cells in the resistance to PyV-induced tumors. Cell lines established from PyV-induced tumors activate NK and γδ T cells both in culture and in vivo and express Rae-1, an NKG2D ligand. Moreover, these PyV tumor cells are killed by NK cells in vitro, and this cytotoxicity is prevented by treatment with NKG2D-blocking antibodies. Our findings demonstrate a protective role for NK and γδ T cells against naturally occurring virus-induced tumors and suggest the involvement of NKG2D-mediated mechanisms.
Zdroje
1. ZocchiMR
FerrariniM
MigoneN
CasoratiG
1994 T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology 81 234 239
2. CorvaisierM
Moreau-AubryA
DiezE
BennounaJ
MosnierJF
2005 V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol 175 5481 5488
3. TodaroM
D'AsaroM
CaccamoN
IovinoF
FrancipaneMG
2009 Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 182 7287 7296
4. TakanamiI
TakeuchiK
GigaM
2001 The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 121 1058 1063
5. CocaS
Perez-PiquerasJ
MartinezD
ColmenarejoA
SaezMA
1997 The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79 2320 2328
6. IshigamiS
NatsugoeS
TokudaK
NakajoA
CheX
2000 Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88 577 583
7. WelshRM
1984 Natural killer cells and interferon. Crit Rev Immunol 5 55 93
8. PenningerJM
WenT
TimmsE
PotterJ
WallaceVA
1995 Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice. Nature 375 241 244
9. GirardiM
OppenheimDE
SteeleCR
LewisJM
GlusacE
2001 Regulation of cutaneous malignancy by gammadelta T cells. Science 294 605 609
10. BenjaminTL
2001 Polyoma virus: old findings and new challenges. Virology 289 167 173
11. SwansonPA2nd
LukacherAE
Szomolanyi-TsudaE
2009 Immunity to polyomavirus infection: the polyomavirus-mouse model. Semin Cancer Biol 19 244 251
12. AllisonAC
LawLW
1968 Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med 127 207 212
13. LawLW
TingRC
LeckbandE
1967 Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc Natl Acad Sci U S A 57 1068 1075
14. AllisonAC
MongaJN
HammondV
1974 Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature 252 746 747
15. Szomolanyi-TsudaE
WelshRM
1996 T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 183 403 411
16. LukacherAE
WilsonCS
1998 Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 160 1724 1734
17. LukacherAE
MoserJM
HadleyA
AltmanJD
1999 Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J Immunol 163 3369 3378
18. BerkeZ
PalmerS
BergmanT
WesterD
SvedmyrJ
1996 A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J Virol 70 3093 3097
19. LukacherAE
MaY
CarrollJP
Abromson-LeemanSR
LaningJC
1995 Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181 1683 1692
20. LiunggrenG
LiunggrenHG
DalianisT
1994 T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198 714 716
21. WangB
BironC
SheJ
HigginsK
SunshineMJ
1994 A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 91 9402 9406
22. DrakeDR3rd
LukacherAE
1998 Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252 275 284
23. McCanceDJ
SebestenyA
GriffinBE
BalkwillF
TillyR
1983 A paralytic disease in nude mice associated with polyoma virus infection. J Gen Virol 64(Pt 1) 57 67
24. Szomolanyi-TsudaE
DundonPL
JorisI
ShultzLD
WodaBA
1994 Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol 144 359 371
25. WilderJA
YuanD
1995 Regulation of IFN-gamma mRNA production in murine natural killer cells. Int Immunol 7 575 582
26. BettsMR
BrenchleyJM
PriceDA
De RosaSC
DouekDC
2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78
27. WatanabeN
HizutaA
TanakaN
OritaK
1995 Localization of T cell receptor (TCR)-gamma delta+T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol 102 167 173
28. KowalczykD
SkorupskiW
KwiasZ
NowakJ
1996 Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett 53 15 18
29. VieyE
FromontG
EscudierB
MorelY
Da RochaS
2005 Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol 174 1338 1347
30. BensussanA
LagabrielleJF
DegosL
1989 TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. Blood 73 2077 2080
31. ChoudharyA
DavodeauF
MoreauA
PeyratMA
BonnevilleM
1995 Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. J Immunol 154 3932 3940
32. LozuponeF
PendeD
BurgioVL
CastelliC
SpadaM
2004 Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 64 378 385
33. KarreK
LjunggrenHG
PiontekG
KiesslingR
1986 Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 675 678
34. ImaiK
MatsuyamaS
MiyakeS
SugaK
NakachiK
2000 Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356 1795 1799
35. RuggeriL
MancusiA
BurchielliE
AversaF
MartelliMF
2007 Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19 142 147
36. BauerS
GrohV
WuJ
SteinleA
PhillipsJH
1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 727 729
37. CerwenkaA
BakkerAB
McClanahanT
WagnerJ
WuJ
2000 Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 721 727
38. CarayannopoulosLN
NaidenkoOV
FremontDH
YokoyamaWM
2002 Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169 4079 4083
39. LanierLL
CorlissBC
WuJ
LeongC
PhillipsJH
1998 Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 703 707
40. WuJ
CherwinskiH
SpiesT
PhillipsJH
LanierLL
2000 DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 192 1059 1068
41. RosenDB
ArakiM
HamermanJA
ChenT
YamamuraT
2004 A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol 173 2470 2478
42. SelinLK
SantolucitoPA
PintoAK
Szomolanyi-TsudaE
WelshRM
2001 Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166 6784 6794
43. EagleRA
TrowsdaleJ
2007 Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7 737 744
44. Szomolanyi-TsudaE
LeQP
GarceaRL
WelshRM
1998 T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 72 6665 6670
45. DunnGP
OldLJ
SchreiberRD
2004 The three Es of cancer immunoediting. Annu Rev Immunol 22 329 360
46. zur HausenH
2008 Novel human polyomaviruses–re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123 247 250
47. Szomolanyi-TsudaE
SeedhomMO
CarrollMC
GarceaRL
2006 T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology 352 52 60
48. WelshRMJr
1978 Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 148 163 181
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
- Susceptibility to Anthrax Lethal Toxin-Induced Rat Death Is Controlled by a Single Chromosome 10 Locus That Includes
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species